Advertisement

Topics

NICE publishes positive guidance for Tremfya for plaque psoriasis

08:49 EDT 14 Jun 2018 | EPM Magazine

The National Institute for Health and Care Excellence (NICE) has published its positive guidance for the first selective interleukin (IL)-23 inhibitor to treat moderate to severe plaque psoriasis.

Original Article: NICE publishes positive guidance for Tremfya for plaque psoriasis

NEXT ARTICLE

More From BioPortfolio on "NICE publishes positive guidance for Tremfya for plaque psoriasis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...